"Kadcyla delivers the drug to the cancer site to shrink the tumor, slow disease progression and prolong survival, " said Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research, in a statement.

CNN: New late-stage breast cancer treatment approved